VetDC Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

VetDC General Information

Description

Developer of cancer treatment drugs designed to treat lymphoma in dogs. The company's drugs identify and evaluate anti-cancer therapies, advance them rapidly in pets, and provide other veterinary services, enabling veterinary doctors to offer pets and their families access to curing cancer in canine companions with FDA-approved drugs.

Contact Information

Website
www.vet-dc.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 320 East Vine Drive
  • Suite 218
  • Fort Collins, CO 80524-2325
  • United States
+1 (303)
Primary Industry
Other Consumer Non-Durables
Vertical(s)
Corporate Office
  • 320 East Vine Drive
  • Suite 218
  • Fort Collins, CO 80524-2325
  • United States
+1 (303)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VetDC Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private 01-Mar-2026 Completed Generating Revenue
9. Grant 31-Dec-2018 Completed Generating Revenue
8. Grant 20-Jul-2018 Completed Generating Revenue
7. Later Stage VC (Series B) 30-Sep-2016 Completed Generating Revenue
6. Grant 20-Dec-2013 Completed Generating Revenue
5. Early Stage VC (Series A2) 01-Dec-2013 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Early Stage VC (Series A1) 01-Nov-2012 Completed Generating Revenue
2. Grant 12-Sep-2012 $7K Completed Generating Revenue
1. University Spin-Out 01-Jan-2010 Completed Generating Revenue
To view VetDC’s complete valuation and funding history, request access »

VetDC Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A2
Series A1 600,000 $0.001000 $0.07 $1.5 22x $0.07 4.6%
To view VetDC’s complete cap table history, request access »

VetDC Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer treatment drugs designed to treat lymphoma in dogs. The company's drugs identify and evaluate anti-c
Other Consumer Non-Durables
Fort Collins, CO
4 As of 2018

Parsippany, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VetDC Competitors (1)

One of VetDC’s competitors is Zoetis, a Corporation company based in Parsippany, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zoetis Corporation Parsippany, NJ
You’re viewing 1 of 1 competitors. Get the full list »

VetDC Patents

VetDC Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2010229468-A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy Inactive 27-Mar-2009
CA-2756067-A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy Inactive 27-Mar-2009
EP-2411387-A2 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy Active 27-Mar-2009
EP-2411387-B1 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy Inactive 27-Mar-2009
US-20100249099-A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy Active 27-Mar-2009 C07D491/08
To view VetDC’s complete patent history, request access »

VetDC Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VetDC Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Colorado State University University
To view VetDC’s complete investors history, request access »

VetDC Acquisitions (1)

VetDC’s most recent deal was a Merger/Acquisition with Pathway Therapeutics. The deal was made on 14-Aug-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Pathway Therapeutics 14-Aug-2013 Merger/Acquisition Drug Discovery
To view VetDC’s complete acquisitions history, request access »

VetDC FAQs

  • When was VetDC founded?

    VetDC was founded in 2010.

  • Where is VetDC headquartered?

    VetDC is headquartered in Fort Collins, CO.

  • What is the size of VetDC?

    VetDC has 4 total employees.

  • What industry is VetDC in?

    VetDC’s primary industry is Other Consumer Non-Durables.

  • Is VetDC a private or public company?

    VetDC is a Private company.

  • What is VetDC’s current revenue?

    The current revenue for VetDC is .

  • How much funding has VetDC raised over time?

    VetDC has raised $8.03M.

  • Who are VetDC’s investors?

    Colorado State University has invested in VetDC.

  • Who are VetDC’s competitors?

    Zoetis is a competitor of VetDC.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process